carbachol has been researched along with Bladder Cancer in 4 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Excerpt | Relevance | Reference |
---|---|---|
" None of the 4 bladder cancer cell lines responded to carbachol." | 3.75 | Defects in muscarinic receptor cell signaling in bladder urothelial cancer cell lines. ( Berkowitz, J; Chai, TC; Li, M; Sun, Y; Tully, BT, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tully, BT | 1 |
Li, M | 1 |
Sun, Y | 1 |
Berkowitz, J | 1 |
Chai, TC | 1 |
Igawa, Y | 1 |
Schneider, T | 1 |
Yamazaki, Y | 1 |
Tatemichi, S | 1 |
Homma, Y | 1 |
Nishizawa, O | 1 |
Michel, MC | 1 |
Neuhaus, J | 1 |
Oberbach, A | 1 |
Schwalenberg, T | 1 |
Stolzenburg, JU | 1 |
Yono, M | 1 |
Yoshida, M | 1 |
Takahashi, W | 1 |
Inadome, A | 1 |
Ueda, S | 1 |
4 other studies available for carbachol and Bladder Cancer
Article | Year |
---|---|
Defects in muscarinic receptor cell signaling in bladder urothelial cancer cell lines.
Topics: Calcium; Carbachol; Cell Line, Tumor; Humans; Muscarinic Agonists; Receptor, Muscarinic M3; Receptor | 2009 |
Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.
Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists | 2012 |
Cultured smooth muscle cells of the human vesical sphincter are more sensitive to histamine than are detrusor smooth muscle cells.
Topics: Calcium; Carbachol; Cells, Cultured; Cystectomy; Histamine; Histamine Agonists; Humans; Male; Myocyt | 2006 |
Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle.
Topics: Aged; Benzhydryl Compounds; Carbachol; Cholinergic Antagonists; Cresols; Dose-Response Relationship, | 2000 |